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Summary: We report a transgenic mouse line that ex-
presses Cre recombinase exclusively in podocytes. Twenty-
four transgenic founders were generated in which Cre
recombinase was placed under the regulation of a 2.5-kb
fragment of the human NPHS2 promoter. Previously, this
fragment was shown to drive beta-galactosidase (-gal)
expression exclusively in podocytes of transgenic mice.
For analysis, founder mice were bred with ROSA26 mice, a
reporter line that expresses -gal in cells that undergo Cre
recombination. Eight of 24 founder lines were found to
express -gal exclusively in the kidney. Histological anal-
ysis of the kidneys showed that -gal expression was con-
fined to podocytes. Cre recombination occurred during the
capillary loop stage in glomerular development. No evi-
dence for Cre recombination was detected in any of 14
other tissues examined. genesis 35:39–42, 2003.
© 2002 Wiley-Liss, Inc.
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INTRODUCTION
Glomerular visceral epithelial cells of the kidney, termed
podocytes, are necessary for the formation and integrity
of the glomerular filtration barrier. Podocytes are in-
creasingly recognized to play a central role in a variety of
glomerular diseases such as diabetic nephropathy and
focal and segmental glomerulosclerosis. Identification of
mutated genes encoding podocyte-specific protein prod-
ucts that cause nephrotic syndrome and subsequent glo-
merulosclerosis has strengthened the hypothesis that the
podocyte plays a central role in maintaining the filtration
barrier of the glomerulus (Kestila et al., 1998; Boute et
al., 2000). In addition to providing convincing evidence
of the importance of the podocyte in maintaining filter
integrity, the work by molecular geneticists has sug-
gested that podocyte injury or loss is directly associated
with the pathological process of glomerulosclerosis.
Work by Kriz, Meyer, Wiggins, and others (Kriz et al.,
1998; Pagtalunan et al., 1997; Kim et al., 2001) investi-
gating both human disease and experimental animal
models has supported the contention that podocyte be-
havior plays a central role in determining outcome in
glomerular disease.
The study of podocyte biology has been hampered by
limitations in available experimental models that both
recapitulate the complex in vivo phenotypes of this cell
and that can be readily and specifically manipulated at
the molecular level. Recent work has provided condi-
tionally immortalized mouse cell lines that express mo-
lecular markers consistent with the in situ podocyte
phenotype (Mundel et al., 1997; Saleem et al., 2002;
Yaoita et al., 2001). However, these cell lines do not
reproduce the complex three-dimensional cyto-architec-
ture and protein expression profile of the podocyte in
situ. These shortcomings limit the utility of these cell
lines for studying the functional role of specific mole-
cules in governing podocyte morphology and the main-
tenance of glomerular filter integrity.
Genetic deletion of genes important in podocyte func-
tion may also result in an embryonic lethal phenotype
that would preclude functional analysis in the mature
podocyte. Eremina et al. (2002) used a 4.125-kb Nphs1
promoter to obtain a mouse line that expresses Cre
recombinase in podocytes. However, in this mouse Cre
recombinase is also expressed in brain. To circumvent
this problem, we sought to develop and characterize a
mouse line expressing Cre recombinase in a truly podo-
cyte-specific fashion.
We have recently identified and characterized a pro-
moter fragment from the human NPHS2 gene that drives
truly podocyte-specific transgene expression in mice
(Moeller et al., 2002). In this work, the identified NPHS2
promoter fragment was successfully used to create a
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transgenic mouse line that expresses Cre recombinase
specifically in podocytes and not in other tissues.
A cassette encoding Cre recombinase was placed un-
der the regulation of the 2.5-kb human NPHS2 promoter
fragment that includes the entire 5 untranslated region
of the NPHS2 (podocin) gene (Fig. 1) (GenBank acces-
sion AF487463). Twenty-four founder 2.5P-Cre mice
were generated by pronuclear injection. For analysis,
2.5P-Cre founder mice were mated to homozygous
ROSA26 mice, a well-characterized reporter line that
expresses beta-galactosidase (-gal) after Cre recombina-
tion (Soriano, 1999). Kidney homogenates of two doubly
transgenic 2.5P-Cre/ROSA26 offspring age 4–8 weeks of
each founder were screened for -gal expression using a
chemiluminescent assay. When crossed with ROSA26
mice, 8 of 24 (33%) founder lines expressed -gal in
kidney. Additional analysis of the homogenates of 14
other tissues derived from eight identified 2.5P-Cre
mouse lines revealed no -gal expression in other tissues
(data not shown).
Subsequent characterization focused on one 2.5P-
Cre founder line (#295). Figure 2 shows expression of
-gal in various tissues of three 2.5P-Cre(#295)/RO-
SA26 offspring compared to nontransgenic litter-
mates. To assure that Cre recombination did not occur
in brain tissue, the entire brain of 2.5P-Cre/ROSA26
offspring was sectioned serially and stained with X-gal.
Again, no -gal activity could be detected anywhere in
the brain (data not shown). These findings are consis-
tent with previous characterization of the 2.5-kb
NPHS2 promoter fragment (Moeller et al., 2002).
Cryosections of kidneys from adult 2.5P-Cre/ROSA26
mice were examined histologically for -gal expres-
sion. -Gal expression was detected in all glomeruli
(Fig. 3A). No -gal expression was seen elsewhere in
the kidney. -Gal expression appeared to be present
in all podocytes of all 2.5P-Cre/ROSA26 mice exam-
ined with no evidence for mosaicism as determined by
GLEPP1 double-label immunohistochemistry (data not
shown). However, ROSA26 mice express cytoplasmic
-gal after Cre excision, so that mosaicism or incom-
plete Cre excision in all podocytes cannot be entirely
ruled out. Newborn 2.5P-Cre/ROSA26 kidneys were
stained with X-gal to determine when Cre excision
occurs during glomerular development. Nephrogen-
esis occurs in a telescoped manner in newborn kidney
that allows the evaluation of all developmental stages
in a single section. In newborn 2.5P-Cre/ROSA26 kid-
neys, -gal expression arose in podocytes during late
capillary loop stage of glomerular development and
persisted in podocytes of mature glomeruli (Fig. 3B).
Expression of Cre recombinase was also examined in
doubly transgenic podocin-Cre/Rosa26 embryos as
early as 8.5 dpc by staining whole embryos with X-gal
and by assaying whole embryo lysates for -gal activity
using the chemiluminescence assay. -Gal activity was
not observed. These findings are also supported by
our previous characterization of the 2.5-kb NPHS2
promoter fragment (Moeller et al., 2002).
Of note, 2 out of 17 analyzed 2.5P-Cre/ROSA26 mice
of founder line #295 did not express significant amounts
of -gal in the kidneys. Thus, penetrance of Cre expres-
FIG. 1. Transgene construct. A 2.5-kb fragment of the human
NPHS2 5 flanking region containing the entire 5 untranslated re-
gion was placed in front of a Cre recombinase cassette. The trans-
gene was released for microinjection from prokaryotic vector se-
quence using KpnI and HindIII. Restriction sites are indicated with
their position relative to the ATG, translation initiation codon; pA,
murine protamine poly-adenylation signal.
FIG. 2. Tissue screen for -gal activity. Tissues from three doubly
transgenic 2.5P-Cre/Rosa26 mice of founder line #295 and from
three singly transgenic ROSA26 littermates were homogenized and
-gal activity was measured using a chemiluminescence assay (first
bar in black 2.5P-Cre/ROSA26 mice; second bar in gray ROSA26
littermates). Data are shown as means of volts (V) of three indepen-
dent experiments with the range indicated by a vertical line. -Gal
activity above background could be detected only in kidney lysates
of doubly transgenic p2.5-Cre/ROSA26 mice. Of note, light emis-
sion measurements (in volts) cannot be compared to measurements
reported in our previous studies (Moeller et al., 2002) since a differ-
ent luminometer was used in this study.
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sion is only 80–90%. A correlation with the animal’s sex,
generation, or age was not obvious. Genetic background
heterogeneity might account for this observation. Cur-
rently, 2.5P-Cre mice are being backcrossed into a C57
BL/6J background.
It should be noted that F1 2.5P-Cre mice of founder
line #295 were interbred to produce homozygous 2.5P-
Cre offspring. At 10 weeks of age 2.5P-Cre (#295) ho-
mozygous mice displayed no overt pathology and were
fertile, indicating that the integration of the transgene
did not disrupt a critical endogenous gene.
The development of a mouse line expressing Cre re-
combinase in a truly podocyte-specific fashion should
provide a valuable tool for examining gene function in
the podocyte.
MATERIALS AND METHODS
Creation of 2.5P-Cre Mice
The lacZ cassette was removed from the vector
p2.5P-nlacF used for the initial characterization of the
2.5-kb NPHS2 promoter fragment (Moeller et al.,
2002). The Cre ORF was PCR-amplified using the prim-
ers CreNcoI.fwd 5aac cat ggg caa ttt act gac cgt aca
cca3 and CreNcoI.rev 5gtc cat ggc taa tcg cca tct tcc
ag3 and inserted into the unique NcoI-site at the
translation initiation codon of p2.5P-(nlacF). The en-
tire 2.5P-Cre transgene was sequenced, liberated from
prokaryotic vector sequence by HindIII and KpnI, and
used for the generation of transgenic mice as de-
scribed previously (Moeller et al., 2000). 2.5P-Cre
transgenic mice were detected by PCR as described
previously (Cushman et al., 2000).
-Gal Assays
Assays of -gal activity in tissue homogenates, X-gal
stainings, and alkaline phosphatase histochemistry (rab-
bit polyclonal anti-vWF; Dako, Carpinteria, CA, 1:500
dilution) of cryosections of kidneys and brain were done
as previously described (Moeller et al., 2000) with the
following modifications: an EG&G Berthold Autolumat
LB953 luminometer was used to measure -gal activity in
tissues (acquisition time: 10 sec).
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